Disposables in downstream processing

Advances in Biochemical Engineering/Biotechnology

Volumn 115, Issue , 2010, Pages 171-183

  Gottschalk, Uwe ^a  

^a SARTORIUS STEDIM BIOTECH GMBH   (Germany)

Author keywords

Buffer volume; Chromatography; Cleaning; Disposable module; Downstream processing; Fouling; Lenticular filter; Membrane adsorber; Validation

Indexed keywords

BIOLOGICAL PRODUCT; PLASTIC;

ANIMAL; ARTICLE; ARTIFICIAL MEMBRANE; BIOREACTOR; CHROMATOGRAPHY; CULTURE TECHNIQUE; DISPOSABLE EQUIPMENT; ECONOMICS; EQUIPMENT; EQUIPMENT DESIGN; FILTRATION; HUMAN; QUALITY CONTROL; STANDARD; VALIDATION STUDY;

ANIMALS; BIOLOGICAL PRODUCTS; BIOREACTORS; CELL CULTURE TECHNIQUES; CHROMATOGRAPHY; DISPOSABLE EQUIPMENT; EQUIPMENT DESIGN; FILTRATION; HUMANS; MEMBRANES, ARTIFICIAL; PLASTICS; QUALITY CONTROL; VALIDATION STUDIES AS TOPIC;

EID: 74949097431     PISSN: 07246145     EISSN: None     Source Type: Book Series    
DOI: 10.1007/10_2008_22     Document Type: Article

References (25)

1. Sinclair A, Monge M (2004) BioProcess Int 2:26
2. Meyeroltmanns F, Schmitz J, Nazlee M (2005) BioProcess Int 3:60
3. Walter JK (1998) In: Subramanian G (ed.) Bioseparation and bioprocessing. processing, quality and characterization, economics, safety and hygiene. Wiley-VCH, p 447
4. Ransohoff T (2004) Poster Presentation at BPD North Carolina Biotechnology Center
5. Gottschalk U (2006) Biopharm Int 19(Suppl):8
6. Muller-Spath T, Morbidelli M (2009) In: Gottschalk U (ed.) Downstream processing of antibodies. Wiley, New York (in press)
7. Kelley B (2007) Biotechnology Prog 23:995
8. Low D, O'Leary R, Pujar NS (2007) J Chromatogr B 848:48
9. European Commission Enterprise Directorate General (2001) Working party on control of medicines and inspections. EU guide to good manufacturing practice, vol. 4, Annex 15, July 2001, Cleaning Validation
10. FDA (2004) Equipment cleaning and maintenance. Code of Federal Regulations (CFR) Part 211.67 Title 21 Rev. FDA, Rockville MD
11. FDA (2006) Guide to inspections validation of cleaning processes. FDA, Rockville MD
12. Gottschalk U (2005) BioPharm Int 18:24
13. Mora J, Sinclair A, Delmdahl N, Gottschalk U (2006) Bioprocess Int 4(Suppl):38
14. CPMP (1996) Note for guidance on virus validation studies. The design, continuation and interpretation of studies validating the inactivation and removal of viruses. CPMP/BWP/268/95
15. Immelmann A, Kellings K, Stamm O, Tarrach K (2005) Bioprocess Int 3:38
16. DiBlasi K, Jornitz MW, Gottschalk U, Priebe PM (2006) BioPharm Int (suppl) 19:6
17. Gottschalk U (2008) Biotechnol Prog 24:496
18. Prashad M, Tarrach K (2006) FISE 9:28
19. Tarrach K, Köhler K, Grimm C (2008) Pharma Tech Eur 20:1
20. Curling J, Gottschalk U (2007) BioPharm Intl 20:70
21. Gebauer K, Thommes J, Kula M (1997) Biotechnol Bioeng 54:181
22. Gottschalk U, Lamproye A, Zhou J, Sinclair A, Reif O-W (2006), Poster Presentation at Recovery of Biological Products XII
23. Zhou J (2006) IBC Technology Transfer for Biopharmaceuticals
24. Sinclair A, Monge M (2002) Pharma Eng 22:20
25. Lim JAC, Sinclair A, Kim DS, Gottschalk U (2007) Poster Presentation at BioProcess Intl 5:60